Commentary on “Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer” by Shaker A. Mousa, Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, United States - Peptide-Conjugated Nanoparticles for Multimodal Nanomedicine
27 , Issue.
Ajay Vikram Singh*
Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR) Max- Dohrn-Strasse 8-10, 10589, Berlin
Read Full-Text article